These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19493207)

  • 21. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer risk in HIV-infected persons: influence of CD4(+) count.
    Clifford GM; Franceschi S
    Future Oncol; 2009 Jun; 5(5):669-78. PubMed ID: 19519206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
    Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
    AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of HIV-1 RNA in dried blood and plasma spots.
    Reigadas S; Schrive MH; Aurillac-Lavignolle V; Fleury HJ
    J Virol Methods; 2009 Oct; 161(1):177-80. PubMed ID: 19523984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.
    Karp CL; Auwaerter PG
    Clin Infect Dis; 2007 Nov; 45(9):1214-20. PubMed ID: 17918087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
    Molina JM; Ait-Khaled M; Rinaldi R; Penco G; Baril JG; Cauda R; Soriano V; Pialoux G; Wire MB; Lou Y; Givens N; Craig C; Nichols WG; Barbosa I; Yeo J;
    J Antimicrob Chemother; 2009 Aug; 64(2):398-410. PubMed ID: 19515730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helminth-HIV coinfection: should we deworm?
    Borkow G; Teicher C; Bentwich Z
    PLoS Negl Trop Dis; 2007 Dec; 1(3):e160. PubMed ID: 18167516
    [No Abstract]   [Full Text] [Related]  

  • 34. [New modification of helminth elimination with oxygen while treating some dermatoses in children].
    Maslov PE
    Sov Med; 1966 Nov; 29(11):114-6. PubMed ID: 6004464
    [No Abstract]   [Full Text] [Related]  

  • 35. [Abacterial purulent meningitis and mass helminth involvement].
    HOFFMANN HU
    Kinderarztl Prax; 1954 Dec; 22(12):556-8. PubMed ID: 14368789
    [No Abstract]   [Full Text] [Related]  

  • 36. Duration of treatment with albendazole for hepatic toxocariasis.
    Yoshikawa M
    Nat Clin Pract Gastroenterol Hepatol; 2009 Mar; 6(3):E1-2. PubMed ID: 19259103
    [No Abstract]   [Full Text] [Related]  

  • 37. [Case of passing pulmonary eosinophils secondary to helminthiasis].
    GOLDSZTEJN J; KUCZBORSKIA J
    Wiad Lek Wars Pol 1948; 1955 Jan; 8(1):41-4. PubMed ID: 14359837
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of associated helminthiasis on the course of dysentery].
    TURCHINS ME
    Sov Med; 1955 Jan; 19(1):32-6. PubMed ID: 14386047
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute abdomen in verminous patients].
    MACHADO JF
    Rev Bras Cir; 1959 Jan; 37(1):23-30. PubMed ID: 13646085
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholinergic receptors on intestine cells of Ascaris suum and activation of nAChRs by levamisole.
    McHugh M; Williams P; Verma S; Powell-Coffman JA; Robertson AP; Martin RJ
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():38-50. PubMed ID: 32470835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.